About Us

FORCE is dedicated to improving the lives of individuals and families affected by hereditary breast and ovarian cancer. We believe no one should have to face hereditary breast and ovarian cancer alone.

About Us > Board of Directors & Advisory Board

About Us
Toggle Menu

Board of Directors & Advisory Board

Board of Directors

Members of FORCE’s board of directors have been personally affected by hereditary cancer or cancer risk, or have a strong interest in reaching out to others whose families have been devastated by this disease. Our board members are dedicated to helping the organization fulfill our mission by helping shape our policies and strategies, connecting us and representing us to other organizations, assisting in outreach, research, education, advocacy, support and development.

Board of Directors

Teri Woodhull - President

Tara Freundlich - Vice President

Debbie Setuain - Treasurer

Carrie Catlin - Secretary

Ellyn Davidson

Sue Friedman 

Melanie Herald


Elaine Kennedy

Allison W. Kurian, M

Tammy Li

Bill Lucken

Rebecca Sutphen, MD

Judy Garber, MD – Director Emeritus

David Nixon – Director Emeritus


FORCE continues to add members to its health care and scientific advisory board.

Monica Alvarado, MS, CGC
Genetics Services Regional Administrator
Kaiser Permanente
Los Angeles, CA
(Cancer Genetic)

Deanna J. Attai, MD, FACS
Assistant Clinical Professor, Department of Surgery
UCLA David Geffen School of Medicine
UCLA Health Burbank Breast Care
(Breast Surgery)

Jennifer L Baker, MD
Assistant Professor of Surgery
UCLA David Geffen School of Medicine
Department of Surgery
(Breast Surgery)

Sharon Bober, PhD
Director, Sexual Health Program
Dana-Farber Cancer Institute/Harvard Medical School
(Sexual Health)

Rachel Brem, MD
Director of Breast Imaging & Intervention
George Washington University Department of Radiology
Washington, DC
(Radiology/Breast Imaging)

Alan Bryce, MD
Medical Director of the Genomic Oncology Clinic 
Mayo Clinic Arizona
Phoenix, AZ
(Medical Oncology, Prostate and Bladder Cancers) 

Lara Cartwright-Smith
The George Washington University
Milken Institute School of Public Health
Washington, DC 
(Health Policy)

Heather Cheng, MD, PhD
Associate Professor
University of Washington/Seattle Cancer Care Alliance
Seattle, WA
(Medical Oncology, Prostate and Bladder Cancers)

Mary Daly, MD, PhD
Chair, Department of Clinical Genetics
Fox Chase Cancer Center
Philadelphia, PA
(Medical Genetics)

Don S. Dizon, MD
Director of Women's Cancers,
Lifespan Cancer Institute
Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital
(Medical Oncology)

Susan Domchek, MD
Executive Director, Basser Research Center for BRCA
Director, MacDonald Women's Cancer Risk Evaluation Center
Basser Professor in Oncology, University of Pennsylvania
(Medical Oncology)

Debra Duquette, CGC
Associate Director
Feinberg School of Medicine, Division of Cardiology & Center for Genetic Medicine
Northwestern University
Chicago, IL

James P. Evans, MD, PhD
Bryson Distinguished Professor of Genetics and Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
(Medical Genetics and Internal Medicine)

Mark Fallick, MD, MBA
New Jersey Urology
Cherry Hill, NJ
(Urology and Fertility)

James Ford, MD
Director, Stanford Clinical Cancer Genetics Program
Stanford Cancer Center
Palo Alto, CA
(Cancer Genetics)

Gregory D Garber, MSW
Director Oncology Support Services
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, PA
(Oncology Support)

Judy E. Garber, MD, MPH
Director, Cancer Risk and Prevention Program
Dana-Farber Cancer Institute
Boston, MA
(Oncology and Cancer Genetics)

Veda N. Giri, MD
Associate Professor - Medical Oncology, Cancer Biology, and Urology
Director, Cancer Risk Assessment and Clinical Cancer Genetics
Sidney Kimmel Cancer Center
Thomas Jefferson University
(Genitourinary Oncology)

Michael J. Hall, MD, MS
Director GI Risk Assessment
Associate Professor of Medicine
Fox Chase Cancer Center
Philadelphia, PA
(Gastrointestinal Oncology and Genetic Risk)

Heather Hampel, CGC
Professor of Clinical Genetics
The Ohio State University
Columbus, OH
(Genetic Counseling)

Karen Hurley, PhD
Cleveland Clinic 
Cleveland, OH
(Clinical Psychology)

Steven Isakoff, MD, PhD
Massachusetts General Hospital
Boston, MA
(Breast Medical Oncology)

Joanne Jeter, MD
Associate Professor of Medicine
The Ohio State University Columbus, OH
(Clinical Cancer Genetics/Skin Cancers)

Noah D. Kauff, MD
Director, Cancer Genetcs
Northwell Health Cancer Institute
(Cancer Genetics)

Andrew Kaunitz, MD
Associate Chair, Department of Obstetrics and Gynecology
University of Florida, College of Medicine, Jacksonville
Jacksonville, FL

Jennifer R. Klemp, PhD, MPH
Risk Assessment Counselor and Program Manager of the Breast Cancer Survivorship Center
University of Kansas Medical Center
Kansas City, Kansas
(Cancer Risk Assessment Counseling)

Allison W. Kurian, MD, MSc
Assistant Professor of Medicine and of Health Research and Policy
Divisions of Oncology and Epidemiology
Stanford University School of Medicine
Stanford, CA
(Medical Oncology)

Christine Laronga, MD
Program Leader, Comprehensive Breast Program
Moffitt Cancer Center and Research Institute
Tampa, FL
(Breast Surgery)

Matthew Lederman, MD
RMA of New York
New York, NY
(Reproductive Endocrinology and Infertility)

Updated 07/10/20

Douglas Levine, MD
Director, Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center
NYU Langone Medical Center
New York, NY

Joshua Levine, MD
Board Certified Plastic Surgeon, Microsurgical Breast Reconstruction
New York, NY
(Breast Reconstruction)

Bryson Katona, MD, PhD
Director, Gastrointestinal Cancer Genetics Program
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA
(Gastrointestinal Cancer Screening and Prevention)

Jennifer Keating Litton, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, TX
(Breast Medical Oncology)

Ellen Matloff, MS
President and CEO
My Gene Counsel
(Genetic Counseling)

Kara N. Maxwell MD, PhD
University of Pennsylvania
Philadelphia, PA
(Medical Oncology/Cancer Genetics)

Bruce Montgomery, MD
University of Washington/Seattle Cancer Care Alliance
Seattle, WA
(Medical Oncology, Prostate and Bladder Cancers)

Bethany Niell, MD, PhD
Section Chief, Division of Breast Imaging, Department of Diagnostic Imaging
Moffitt Cancer Center
Tampa, FL
(Radiology/Breast Imaging)

Barbara Norquist, MD
Assistant Professor, Dept. of OB/GYN
University of Washington
(Gynecologic Oncology, Ovarian Cancer Prevention)

Allyson Ocean, MD
Weill Cornell Medicine
New York, NY
(Gastrointestinal oncology)

Kenneth Offit, MD
Chief, Clinical Genetics Service
Memorial Sloan Kettering Cancer Center
New York, NY
(Medical Oncology)

Nadereh Pourat, PhD
Professor, Department of Health Policy and Management
Los Angeles, CA
(Health Policy)

Anya Prince, JD, MPP
University of Iowa College of Law
Iowa City, IA
(Legal and Insurance Issues)

Jana Pruski-Clark, CGC
Vice President, Cancer Genetics Services
Roseville, CA
(Genetic Counseling)

Timothy R. Rebbeck, PhD
Professor Epidemiology, Harvard T.H. Chan School of Public Health, Professor Medical Oncology, Dana-Farber Cancer Institute
Boston, MA
(Epidemiology )

Kim A Reiss (Reiss Binder), M.D.
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Philadelphia, PA
(Medical Oncology)

BJ Rimel, MD
Cedars-Sinai Medical Center
Los Angeles, CA

Jennifer Scalia Wilbur, MS
Clinical Program Manager/Cancer Genetic Counselor
Cancer Genetics and Prevention Program
Warren Alpert Medical School of Brown University Program in Women's Oncology
Women & Infants’Hospital
Providence, RI
(Genetic Counseling)

Victoria Seewaldt, MD
Professor and Chair, Department of Population Sciences
Associate Director, Comprehensive Cancer Center
City of Hope
Duarte, CA
(Medical Oncology)

Leigha Senter-Jamieson, CGC
Associate Professor
The Ohio State University
Columbus, OH
(Genetic Counseling)

Payal Shah, MD
Assistant Professor
Abramson Cancer Center
University of Pennsylvania
(Breast Medical Oncology)

Diljeet Singh, MD DrPh
Mid-Atlantic Permanante Medical Group
Washington, DC
(Gynecology/Oncology, Integrative Medicine)

Rebecca Sutphen, MD, FACMG
Professor of Genetics
College of Medicine
University of South Florida
Tampa, FL

Elizabeth Swisher, MD
Department of Obstetrics & Gynecology
Medical Director, Breast and Ovarian Cancer Prevention Program
University of Washington School of Medicine
Seattle, WA

Melinda Telli, MD
Assistant Professor of Medicine
Stanford University
Division of Medical Oncology
Stanford, CA
(Medical Oncology)

Kenneth Tercyak, PhD
Associate Professor
Leader, Cancer Prevention & Control Program
Director of Behavioral Prevention Research
Georgetown University Medical Center
Lombardi Cancer Center
Washington, DC

Nadine M. Tung, MD
Beth Israel Deaconess Medical Center
Associate Professor, Medicine, Harvard Medical School
Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center
Boston, MA
(Medical Oncology/Cancer Genetics)

Matthew Yurgelun, MD
Director, Lynch Syndrome Center
Dana-Farber Cancer Institute
Boston, MA
(Gastrointestinal Oncology)


FORCE:Facing Our Risk of Cancer Empowered